Related Experiment Videos
RNA sequence analysis of a perinatal lethal osteogenesis imperfecta mutation
E Patterson1, E Smiley, J Bonadio
1Howard Hughes Medical Institute, University of Michigan, Ann Arbor 48109-0650.
The Journal of Biological Chemistry
|June 15, 1989
Summary
Researchers identified a novel glycine to valine substitution in type I procollagen, a key protein in bone development. This genetic mutation is linked to the lethal form of osteogenesis imperfecta, impacting bone fragility.
Area of Science:
- Genetics
- Molecular Biology
- Biochemistry
Background:
- Osteogenesis imperfecta (OI) is a group of genetic disorders characterized by bone fragility.
- The perinatal lethal form of OI is often caused by mutations affecting type I procollagen, a crucial protein for bone structure.
- These mutations can disrupt procollagen assembly, secretion, and lead to abnormal posttranslational modifications.
Observation:
- A novel mutation was identified in cells from patients with perinatal lethal osteogenesis imperfecta.
- The mutation was localized to the alpha 1(I) chain of type I procollagen.
- Abnormal posttranslational modifications within the triple helical domain of mutant procollagen molecules were observed.
Findings:
- An indirect RNA sequence analysis method was used to characterize the mutation.
- Sequence analysis of cDNA and genomic DNA revealed a heterozygous Glycine (Gly) to Valine (Val) substitution at residue 256 of the alpha 1(I) chain.
- This Gly----Val substitution is a newly identified cause of lethal OI and is located at the most amino-terminal position within the alpha 1(I) chain triple helical domain reported to date.
Implications:
- This finding expands the known spectrum of mutations causing lethal osteogenesis imperfecta.
- Understanding this specific mutation provides insights into the critical role of the amino-terminal region of the alpha 1(I) chain in collagen stability.
- The characterization of this mutation may aid in future diagnostic and therapeutic strategies for severe forms of OI.